Damiano D. Abeni - Epidemiology

Author Information

Damiano D. Abeni is a renowned expert in the field of epidemiology, with a particular focus on dermatological conditions. He is affiliated with the Clinical Epidemiology Unit at IDI-IRCCS in Rome, Italy. His work primarily involves exploring the epidemiological aspects of skin diseases and their impact on patients' quality of life.

Research Contributions

Damiano D. Abeni has made significant contributions to the understanding of dermatological conditions through his research. His recent work includes studies on gliptin-associated bullous pemphigoid, the quality of life in patients with breast cancer-related lymphedema, psychological interventions for skin disease patients, and attitudes towards actinic keratosis and non-melanoma skin cancer treatments. Abeni's research also explores the genetic and environmental factors associated with skin conditions and their implications for treatment and patient care.

Aliases

Throughout his academic career, Damiano D. Abeni has been referenced by various name variations, including Da Abeni, Damiano D. Abeni, Damiano D Abeni, D. Abeni, D D Abeni, Damiano Abeni, and D Abeni.

Publication and Citation Metrics

Metric	Value
Total Citation Count	11,345
H-index	62
Total Paper Count	328

Publications:

Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: results from a multicenter study.

DOI: 10.1016/j.jaad.2022.02.036

Year: 2022

Cross-Cultural Adaptation and Preliminary Validation of Upper Limb Lymphedema Quality of Life Questionnaire (ULL-27) in Italian Female Patients with Breast Cancer-Related Lymphedema.

DOI: 10.1089/lrb.2021.0080

Year: 2022

Does Guided Written Disclosure Reduce Distress and Improve Psychological Functioning in Patients with Skin Diseases?

DOI: 10.3390/ijerph19052943

Year: 2022

Attitudes among dermatologists regarding actinic keratosis treatment options

DOI: 10.4081/dr.2022.9392

Year: 2022

Attitudes among dermatologists regarding non-melanoma skin cancer treatment options

DOI: 10.1007/s12672-021-00421-w

Year: 2021

The Burden of Autosomal Recessive Congenital Ichthyoses on Patients and their Families: An Italian Multicentre Study.

DOI: 10.2340/00015555-3822

Year: 2021

Factors associated with sunbed use among 3692 outpatients in 18 centers of the Italian Cancer League (LILT)

DOI: 10.21203/rs.3.rs-776211/v1

Year: 2021

Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches

DOI: 10.1177/12034754211039993

Year: 2021

Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes

DOI: 10.1111/jdv.17725

Year: 2021

Involvement of transcribed lncRNA uc.291 and SWI/SNF complex in cutaneous squamous cell carcinoma

DOI: 10.1007/s12672-021-00409-6

Year: 2021

What is the National Immunisation Program (NIP)?

How is Program Evaluation Conducted?

What are the Advantages of Using Spectrophotometry in Epidemiological Studies?

How Do Epidemiologists Measure Health Outcomes?

What is Real-Time Collaboration in Epidemiology?

What Tools are Used for Prediction?

What is the Tuberculin Skin Test?

What is Survival in Epidemiology?

Why is Disease Causation Complex?

What Methods Are Used to Study Biological Effects?

Partnered Content Networks

Relevant Topics